emend

Generic: fosaprepitant dimeglumine

Labeler: merck sharp & dohme llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name emend
Generic Name fosaprepitant dimeglumine
Labeler merck sharp & dohme llc
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

fosaprepitant dimeglumine 150 mg/5mL

Manufacturer
Merck Sharp & Dohme LLC

Identifiers & Regulatory

Product NDC 0006-3061
Product ID 0006-3061_20906e8e-8a3e-4c45-a657-6d4c1945af09
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022023
Listing Expiration 2027-12-31
Marketing Start 2017-02-03

Pharmacologic Class

Classes
cytochrome p450 2c9 inducers [moa] cytochrome p450 3a4 inducers [moa] cytochrome p450 3a4 inhibitors [moa] neurokinin 1 antagonists [moa] substance p/neurokinin-1 receptor antagonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00063061
Hyphenated Format 0006-3061

Supplemental Identifiers

RxCUI
1731077 1731082
UPC
0300063061001
UNII
D35FM8T64X

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name emend (source: ndc)
Generic Name fosaprepitant dimeglumine (source: ndc)
Application Number NDA022023 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 150 mg/5mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00) / 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)
source: ndc

Packages (1)

0006-3061-00 1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00) / 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)

Ingredients (1)

fosaprepitant dimeglumine (150 mg/5mL)

Linked Drug Pages (1)

EMEND ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "20906e8e-8a3e-4c45-a657-6d4c1945af09", "openfda": {"upc": ["0300063061001"], "unii": ["D35FM8T64X"], "rxcui": ["1731077", "1731082"], "spl_set_id": ["8d66803a-6811-4c29-9c57-e16acfa87f21"], "manufacturer_name": ["Merck Sharp & Dohme LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0006-3061-00)  / 5 mL in 1 VIAL, SINGLE-DOSE (0006-3061-01)", "package_ndc": "0006-3061-00", "marketing_start_date": "20170203"}], "brand_name": "EMEND", "product_id": "0006-3061_20906e8e-8a3e-4c45-a657-6d4c1945af09", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Neurokinin 1 Antagonists [MoA]", "Substance P/Neurokinin-1 Receptor Antagonist [EPC]"], "product_ndc": "0006-3061", "generic_name": "FOSAPREPITANT DIMEGLUMINE", "labeler_name": "Merck Sharp & Dohme LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMEND", "active_ingredients": [{"name": "FOSAPREPITANT DIMEGLUMINE", "strength": "150 mg/5mL"}], "application_number": "NDA022023", "marketing_category": "NDA", "marketing_start_date": "20170203", "listing_expiration_date": "20271231"}